Scancell
UK - OxfordBiotechnology
Focus: Scancell is a UK-based biotechnology company founded in 1996 specializing in cancer vaccines and immunotherapies across oncology and infectious diseases. As a public company, it operates in the competitive immuno-oncology space with a focus on therapeutic vaccine development.
Profile data last refreshed 21h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Scancell
AI assessmentNot HiringNo open roles listed right now. Follow Scancell to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
COVIDITY
COVID-19Clinical Trials (1)
NCT05047445A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection
Phase 1Help build intelligence for Scancell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.